Literature DB >> 10449435

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

P Garred1, T Pressler, H O Madsen, B Frederiksen, A Svejgaard, N Høiby, M Schwartz, C Koch.   

Abstract

Mannose-binding lectin (MBL) is a key factor in innate immunity, and lung infections are the leading cause of morbidity and mortality in cystic fibrosis (CF). Accordingly, we investigated whether MBL variant alleles, which are associated with recurrent infections, might be risk factors for CF patients. In 149 CF patients, different MBL genotypes were compared with respect to lung function, microbiology, and survival to end-stage CF (death or lung transplantation). The lung function was significantly reduced in carriers of MBL variant alleles when compared with normal homozygotes. The negative impact of variant alleles on lung function was especially confined to patients with chronic Pseudomonas aeruginosa infection. Burkholderia cepacia infection was significantly more frequent in carriers of variant alleles than in homozygotes. The risk of end-stage CF among carriers of variant alleles increased 3-fold, and the survival time decreased over a 10-year follow-up period. Moreover, by using a modified life table analysis, we estimated that the predicted age of survival was reduced by 8 years in variant allele carriers when compared with normal homozygotes. Presence of MBL variant alleles is therefore associated with poor prognosis and early death in patients with CF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449435      PMCID: PMC408526          DOI: 10.1172/JCI6861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark.

Authors:  M Schwartz; H K Johansen; C Koch; N J Brandt
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  Survival patterns in cyctic fibrosis.

Authors:  W J Warwick; R E Pogue; H U Gerber; C J Nesbitt
Journal:  J Chronic Dis       Date:  1975-12

3.  Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

Authors:  W Goldstein; G Döring
Journal:  Am Rev Respir Dis       Date:  1986-07

Review 4.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1977

5.  Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.

Authors:  H K Johansen; M Nir; N Høiby; C Koch; M Schwartz
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein.

Authors:  M E Taylor; P M Brickell; R K Craig; J A Summerfield
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency.

Authors:  P Garred; H O Madsen; B Hofmann; A Svejgaard
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

9.  The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10.

Authors:  K Sastry; G A Herman; L Day; E Deignan; G Bruns; C C Morton; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.

Authors:  R A Ezekowitz; L E Day; G A Herman
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  97 in total

Review 1.  SNPing away at innate immunity.

Authors:  S J Chanock; C B Foster
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis.

Authors:  M Gabolde; D Hubert; M Guilloud-Bataille; C Lenaerts; J Feingold; C Besmond
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

Review 3.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 4.  Atypical cystic fibrosis--diagnostic and management dilemmas.

Authors:  Colin Wallis
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

5.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity.

Authors:  David L Masica; Patrick R Sosnay; Karen S Raraigh; Garry R Cutting; Rachel Karchin
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

Review 7.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 8.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

9.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

Review 10.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.